Healthy CD19+ B Cells
Healthy CD19 B Cells are isolated from the peripheral blood of IRB-consented healthy donors, cryopreserved in CryoStor CS10 at ≥90% CD19+ purity. Ideal for B cell activation and differentiation assays, BCR signalling, antibody discovery, CD19+ target cells for CAR-T and CAR-NK work, and immunophenotyping panel development. Donor selection by age, sex, ethnicity, CMV/EBV serostatus, HLA, and blood type. Disease-state CD19+ B cells are also available.
| Lot # | Condition | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|
| 79730 | Normal (Healthy) | Caucasian | 40 | Male | United States |
None as of 2025 None as of 2023
|
5 | $2,000.00 | |
| 77818 | Normal (Healthy) | Asian/Pacific Islander | 60 | Female | United States | 4 | $2,000.00 | ||
| 79730 | Normal (Healthy) | Caucasian | 40 | Male | United States |
None as of 2025 None as of 2023
|
4 | $1,000.00 | |
| 77818 | Normal (Healthy) | Asian/Pacific Islander | 60 | Female | United States | 4 | $1,000.00 | ||
| 79635 | Normal (Healthy) | Caucasian | 22 | Female | United States | 2 | $1,000.00 | ||
| 79438 | Normal (Healthy) | Hispanic/Latino | 30 | Female | United States |
Albuterol Inhaler PRN
|
4 | $1,000.00 | |
| 79438 | Normal (Healthy) | Hispanic/Latino | 30 | Female | United States |
Albuterol Inhaler PRN
|
2 | $2,000.00 | |
| 79635 | Normal (Healthy) | Caucasian | 22 | Female | United States | 1 | $2,000.00 | ||
| 78092 | Normal (Healthy) | Hispanic/Latino | 44 | Male | United States |
No meds
|
4 | $1,000.00 | |
| 78119 | Normal (Healthy) | Caucasian | 22 | Female | United States |
Lexapro 10mg QD Wellbutrin 300mg QD Lamotrigine 100mg QD Amitriptyline 10mg QD Birth Control Pill QD
|
2 | $1,000.00 |
Healthy CD19+ B Cells for Immunology and Antibody Discovery Research
Healthy CD19 B Cells are purified from the peripheral blood of healthy, IRB-consented, clinically screened adult donors and cryopreserved within 24 hours of collection. B lymphocytes are the effectors of humoral immunity, and these primary human cells serve as the baseline reference material for studying antibody production, B cell receptor (BCR) signalling, and immune regulation. Disease-state CD19+ B cells are also available for comparative work.
B Cell Biology and Isolation
- CD19 is the canonical pan-B-cell marker, expressed from the pro-B stage through to activated B cells and most plasmablasts, and lost on fully differentiated plasma cells. It is also the most clinically established target antigen in B-cell-directed cell therapy.
- Cells are isolated from apheresis or peripheral blood mononuclear cell starting material by immunomagnetic selection. Negative selection leaves the B cell surface untouched and is preferred where downstream receptor engagement or activation state matters; positive selection is available where maximum purity is the priority.
- The isolated fraction contains the physiological spread of circulating B cell subsets, distinguishable by CD27, IgD, CD24, and CD38 expression: transitional and naive B cells, unswitched and class-switched memory B cells, and a small plasmablast population.
- CD19 is physically and functionally coupled to the BCR complex, where it acts with CD21 and CD81 as a co-receptor that lowers the threshold for antigen-driven activation – making these cells directly suited to signalling studies.
- Primary human B cells are short-lived in culture without support, so activation systems supplying CD40 ligand, IL-4, IL-21, or TLR9 stimulation are typically used for proliferation, class switching, and differentiation assays.
- Cryopreservation in CryoStor CS10 with processing inside 24 hours of collection preserves viability and function for thaw-and-use assay formats.
Donor Selection and Characterisation
- Age band and sex assigned at birth
- Race and ethnicity
- CMV and EBV serostatus, which is relevant to memory B cell composition and to viral antigen-specific work
- HLA type where typing is available, for use in cell therapy target-cell and allogeneic response studies
- ABO and Rh blood type
- Body mass index, medication and allergy history, and repeat-donor availability for longitudinal or paired-lot studies
Product Features
- Research Use Only (RUO), CD19+ B cells
- Isolated from healthy, clinically screened donors
- High purity and viability (≥90% CD19+ cells)
- Cryopreserved using CryoStor® CS10 media
- Processed within 24 hours of collection
- Negative or positive selection available on request
- Standard or custom aliquot sizes
- IRB-approved protocols and HIPAA-compliant handling
De-identified Donor Data
- Comprehensive donor screening and verified health status
- Demographic data: age, sex assigned at birth, race/ethnicity
- Medication and allergy history available
- Infectious disease testing results, including CMV and EBV serology
- HLA type and blood type where available
Applications
- B cell activation, proliferation, and differentiation assays using CD40L, IL-4, IL-21, or TLR agonist stimulation
- Antibody production and class-switch recombination studies
- B cell receptor signalling analysis, including phosphoflow and kinase inhibitor profiling
- Antibody discovery workflows, including single B cell cloning and BCR repertoire sequencing
- CAR-T and CAR-NK development as CD19+ target cells for cytotoxicity, killing, and potency assays
- Immunophenotyping panel design, optimisation, and instrument standardisation
- Drug screening and mechanism-of-action work for B-cell-depleting antibodies, bispecific engagers, and BTK inhibitors
- Baseline reference material for comparison against disease-state B cell products
Other Healthy Immune Cell Subsets
Compliance and Quality Assurance
- IRB-approved collections with 21 CFR Part 11-compliant e-consent
- Standardized processing and cryopreservation protocols
- HIPAA-compliant donor data protection
Ordering & Customization
Healthy CD19 B Cells are available in standard or custom aliquot sizes. For pricing, international shipping, documentation, or regulatory support, please contact learnmore@sanguinebio.com. To browse the full range of isolated B cell products and current availability, visit our human CD19+ B cells page.
Protocols & Documentation
-
Download
Immune Cell Isolation
Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
CD19+ B Cells
Frequently Asked Questions
Ask a Question
Need a custom CD19+ B Cells cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.